Literature DB >> 24894178

Role of microRNAs in B cell leukemias and lymphomas.

A Schmidt, R Küppers1.   

Abstract

MicroRNAs (miRNAs) are a class of small (18~25 nucleotides long) non-coding RNAs that regulate gene expression on the post-transcriptional level. During the last decade, the field of miRNA research has been exponentially expanding, revealing the widespread role of these molecules in numerous biological processes. Aberrant miRNA expression has been documented in multiple haematologic malignancies, including B cell lymphomas. There is compelling evidence that miRNAs can function as oncogenes or tumor suppressor genes in lymphoid malignancies. In this review, we recapitulate the current knowledge of miRNA expression in B cell malignancies and discuss the accumulating evidence for a major role of miRNA deregulation in the development of B cell-derived lymphoid tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24894178     DOI: 10.2174/1566524014666140603095414

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  4 in total

Review 1.  Polycomb genes, miRNA, and their deregulation in B-cell malignancies.

Authors:  Gang Greg Wang; Kyle D Konze; Jianguo Tao
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

2.  A microRNA involved in the germinal center reaction.

Authors:  Ralf Küppers
Journal:  Blood       Date:  2014-07-10       Impact factor: 22.113

3.  miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.

Authors:  Nahikari Bartolomé-Izquierdo; Virginia G de Yébenes; Angel F Álvarez-Prado; Sonia M Mur; Juan A Lopez Del Olmo; Sergio Roa; Jesus Vazquez; Almudena R Ramiro
Journal:  Blood       Date:  2017-02-10       Impact factor: 22.113

4.  MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma.

Authors:  Tingting Wang; Mingyu Du; Wenjun Zhang; Hui Bai; Li Yin; Wei Chen; Xia He; Qi Chen
Journal:  Onco Targets Ther       Date:  2019-12-19       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.